Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells. - Wikidata - awgldk - TriplyDB

Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells.

Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells.

http://www.wikidata.org/entity/Q44765733

about

Moderate strength (0.23-0.28 T) static magnetic fields (SMF) modulate signaling and differentiation in human embryonic cells Carbohydrate engineered cells for regenerative medicine.Hexosamine analogs: from metabolic glycoengineering to drug discovery.Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs Designing a binding interface for control of cancer cell adhesion via 3D topography and metabolic oligosaccharide engineering.Deciphering glycan linkages involved in Jurkat cell interactions with gold-coated nanofibers via sugar-displayed thiols.Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells.Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations The systems biology of glycosylation.Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis.Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery.Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines Short-chain fatty acid-modified hexosamine for tissue-engineering osteoarthritic cartilage.Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery Metabolic glycoengineering: sialic acid and beyond Metabolic oligosaccharide engineering: implications for selectin-mediated adhesion and leukocyte extravasation.Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib.Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.Metabolic Remodeling of Cell-Surface Sialic Acids: Principles, Applications, and Recent Advances.Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid.Metabolic Glycoengineering with N-Acyl Side Chain Modified Mannosamines.Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.Metabolic monosaccharides altered cell responses to anticancer drugs.Applying Acylated Fucose Analogues to Metabolic Glycoengineering A novel approach to decrease sialic acid expression in cells by a C-3-modified N-acetylmannosamine.Esterified Trehalose Analogues Protect Mammalian Cells from Heat Shock.An inhibitor of O-glycosylation induces apoptosis in NIH3T3 cells and developing mouse embryonic mandibular tissues.Experimental Design Considerations for In Vitro Non-Natural Glycan Display via Metabolic Oligosaccharide Engineering.A novel sugar analog enhances sialic acid production and biotherapeutic sialylation in CHO cells.Synthesis of non-natural ManNAc analogs for the expression of thiols on cell-surface sialic acids.Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.Safety and Optimization of Metabolic Labeling of Endothelial Progenitor Cells for Tracking Improving Immunotherapy Through Glycodesign

P2860

Q33490273-A49C239A-9CE9-4A09-8DCB-83A3CC4094B9 Q34545778-E4649C20-6AAC-4AE2-8BCB-289900168AD8 Q34573479-AE3842F8-B69B-4BF7-964E-FA6C277075D0 Q34573505-9B4BE88D-2C58-4959-A394-10B6F4B4C3B0 Q35013793-4EE95834-C6F4-4425-8B22-248753A75F70 Q35165014-A7990645-5F59-4C37-9201-A8C49F59FF55 Q35615401-CC2157A7-18A3-4B41-A4BB-BA0EFC8D1892 Q35710052-CFD21521-96FC-4DD5-872A-61B8E2232900 Q35785590-3DD3DB16-D485-4BE7-B203-0831FEAA5805 Q35905293-09285A34-F76E-4437-A294-E0897005A1CE Q36089893-AA0D5E19-BB9A-4554-81AC-B52939B38B41 Q36488687-7DD1346D-1E3D-4323-B401-95B982768A54 Q36868822-32910DFE-F8B3-4BBB-97F4-A76077839E58 Q37052278-562C20C6-F4E1-4C08-B3F5-14AA6930C196 Q37133422-55A2CCAC-1182-4262-9F98-4A5DA241ECEA Q37290063-4C762536-ED54-4E65-B762-05985490C94E Q37405391-88FBF737-B545-4A69-BA88-02FF4F2623A2 Q37950862-7CC87731-8BEE-4872-B76E-8F02FB5B2575 Q38301000-50FD27F6-4D12-413D-A09F-BB4E0ED92768 Q38452524-482811AC-B236-4884-AA3F-F4077F9D4CAA Q38634704-C52A7D79-6585-4D42-B7D8-66914398542A Q38715644-BC25F0ED-59A6-4FA5-8F0B-66DFCA70B85E Q38902441-A472B74D-E809-46F0-A3A6-D557197AADCF Q39031683-1A264ED2-38C5-4CE9-9D40-B59EE344D0A7 Q39367521-8B25C88C-6B08-4EF5-ABCC-AC8B33F53CF2 Q41704611-1D7115B3-3744-4D56-A7B0-C65E32846CF1 Q42234364-2AFEF6B0-727F-4AED-8595-28A2B8BB5B19 Q42798971-C9F03FAE-D756-4641-A32A-DE7C3DC4663B Q42825914-A4EC5891-BD46-413C-BA8F-5A3E0AF42E16 Q47172587-12272631-DBA7-4962-9CE9-3EEB24D2C72B Q48126423-D33AF916-5959-42F9-8BBE-7D91B97979EF Q51032374-28DB1AF7-BBF3-41D7-896C-587200259B42 Q54977678-FA561670-DE48-47C3-837F-FDACDCBCC9A7 Q58765392-17D151C9-9141-4C17-8B9D-923F21C6210C Q59132146-13091994-6DA5-42DF-B9A0-A601CA839211

P2860

Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells.

http://www.wikidata.org/entity/Q44765733

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Characterization of the metabo ...... amine analogs in Jurkat cells.

@en

Characterization of the metabo ...... amine analogs in Jurkat cells.

@nl

type

label

Characterization of the metabo ...... amine analogs in Jurkat cells.

@en

Characterization of the metabo ...... amine analogs in Jurkat cells.

@nl

prefLabel

Characterization of the metabo ...... amine analogs in Jurkat cells.

@en

Characterization of the metabo ...... amine analogs in Jurkat cells.

@nl

P1433

Q44765733-EB7AB650-D96E-4EFE-96A1-A6A948011A70

P1476

Q44765733-1D7A7558-2794-418A-8B9B-B6317DD59DAF

P2093

Q44765733-22CC2491-B5EE-4246-BB6D-7F5B04C9C111

Q44765733-58EE4316-7FEF-4E54-B63B-1C51380D8C11

Q44765733-98146F52-32CE-48B5-AB58-621F705FAEEC

Q44765733-BF893F15-7D18-418B-BB3E-D7030250977B

P2860

Q44765733-014D1E4C-1B39-478F-BFFE-1CEFFFA685B9

Q44765733-0385AAF4-FBCC-4F0C-B96A-FF0E201512D1

Q44765733-06FBF35E-6CE4-40E6-9FE2-1447D80E2702

Q44765733-11EAE38F-C78D-4DC2-B44B-BFAE0BCAAFE9

Q44765733-1835A4AA-7C08-428B-B36C-A3F7547BB771

Q44765733-1B6F49B7-1268-4BB6-B1DC-9DE2C1DA540C

Q44765733-23CB0653-D549-4A16-A1B4-B536D6920A35

Q44765733-274D438D-2E4E-4557-8B38-AF75C4EE32D8

Q44765733-2962469D-E90A-4A79-9470-74A7A60204FF

Q44765733-299AC96E-C4B2-4DFC-8912-307A80E68F60

P304

Q44765733-8FA5185E-DF68-4769-A8E7-F0DC20CA753E

P31

Q44765733-A79E7D71-7A1B-4CBA-8869-74F96570C60A

P356

Q44765733-73FA28E6-09C2-41B1-AD53-EBB49A001FAF

P407

Q44765733-5CD2D457-2249-4CA4-8DAF-4A8F6217827F

P433

Q44765733-AC2F1449-55ED-4D34-BA3F-49024965F0B1

P478

Q44765733-82FBF2B6-8707-4655-9C70-3B0A484B8331

P50

Q44765733-231F364B-E064-4B4F-8A6D-1C805D8FB05B

Q44765733-2D924B31-DFA7-40A2-A721-44CD725CCA43

Q44765733-48B0DD7B-A6D7-48FE-AF9F-2703E5904F2A

P577

Q44765733-236D9E28-51DA-4637-AB5B-AE3B7BF33EC4

P5875

Q44765733-208EC483-D951-4249-BEF5-E8D885A17AD3

P698

Q44765733-8872C562-2F29-47AE-A74B-E9E0823A6079

P356

P1433

Journal of Biological Chemistry

P1476

Characterization of the metabo ...... samine analogs in Jurkat cells

@en

P2093

Eun Jeong Kim

http://www.w3.org/2001/XMLSchema#string

Gautam Baskaran

http://www.w3.org/2001/XMLSchema#string

Kevin J Yarema

http://www.w3.org/2001/XMLSchema#string

Scarlett Goon

http://www.w3.org/2001/XMLSchema#string

P2860

Expression cloning and functional characterization of human cDNA for ganglioside GM3 synthase

UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation

Molecular cloning and expression of Galbeta1,3GalNAc alpha2, 3-sialyltransferase from human fetal liver

Molecular cloning and expression of mouse GD1alpha/GT1aalpha/GQ1balpha synthase (ST6GalNAc VI) gene

Cloning and expression of the human N-acetylneuraminic acid phosphate synthase gene with 2-keto-3-deoxy-D-glycero- D-galacto-nononic acid biosynthetic ability

Genomic organization and chromosomal mapping of the Gal beta 1,3GalNAc/Gal beta 1,4GlcNAc alpha 2,3-sialyltransferase

Caspases: the executioners of apoptosis

Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme

Cell surface engineering by a modified Staudinger reaction

Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis

P304

18342-18352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M400205200

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

279

http://www.w3.org/2001/XMLSchema#string

P50

Srinivasa-Gopalan Sampathkumar

P577

2004-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6270874

http://www.w3.org/2001/XMLSchema#string

P698

14966124

http://www.w3.org/2001/XMLSchema#string